{
    "nctId": "NCT00639210",
    "briefTitle": "BREAST CANCER AND EXERCISE",
    "officialTitle": "BREAST CANCER AND EXERCISE BREX: A Multicenter Phase III Open Randomised Trial of the Efficacy of Exercise in the Prevention of Long-term Adverse Effects of Adjuvant Treatments and Breast Cancer Recurrences in Women With Primary Breast Cancer.",
    "overallStatus": "COMPLETED",
    "conditions": "Prevent Osteoporosis and Osteoporotic Fractures, Improve Quality of Life, Improve Weight Control, and Muscular and Cardiovascular Fitness, Help the Patients to Return to Working Life, Reduce the Risk of Breast Cancer Recurrence, Reduce All-cause Mortality in Patients With Primary Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 573,
    "primaryOutcomeMeasure": "The aim of the study is to investigate whether regular exercise after adjuvant treatments of breast cancer could prevent osteoporosis and improve quality of life.",
    "eligibilityCriteria": "Inclusion Criteria: Histologically proven invasive breast cancer T1-4N0-3M0, pre- or postmenopausal breast cancer patient treated with adjuvant chemotherapy or radiotherapy within 4 months or patient who has started adjuvant endocrine therapy (antiestrogens, aromatase inhibitors, LHRH agonists, or combinations) no later than 4 months earlier,age from 35 to 68 years,signed informed consent prior to beginning protocol specific procedures\n\nExclusion Criteria:\n\n* Prior malignancy except basal cell carcinoma or in situ cervix carcinoma\n* Male gender\n* Haematogenous metastases (M1)\n* No systemic adjuvant therapy\n* Postmenopausal women treated with antiestrogens, tamoxifen or toremifene, adjuvant treatment only (+/- radiotherapy)\n* Pregnancy or recent lactation (\\< 1 year)\n* Severe cardiac disease (New York Heart Association class III or greater), myocardial infarction within 12 months, uncontrolled hypertension\n* Verified osteoporosis (proximal femur or lumbar spine t-score \\< -2.5 or fracture without trauma)\n* Concomitant medications affecting calcium and bone metabolism such as bisphosphonates, calcitonin, PTH, SERMs, oral corticosteroids (over 6 months), anticonvulsants (fenytoin, carbamazepine) and prolonged heparin therapy\n* Other diseases affecting calcium and bone metabolism such as hyperthyroidism, newly diagnosed hypothyroidism, primary hyperparathyroidism, renal failure, chronic hepatic diseases, organ transplant, Cushing's syndrome, rheumatoid arthritis, chronic bowel diseases such as celiac disease, Chron disease or history of total ventricular resection\n* Other serious illness or medical condition, which could be contraindication for exercise\n* Patients not capable of training (severe knee arthrosis, severe ligamental or cartilage injuries at lower extremities)\n* Residence more than one hour from the exercise centre\n* Competitive athlete",
    "sex": "FEMALE",
    "minimumAge": "35 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}